An Act relative to promoting comprehensive transparency in the pharmaceutical industry
- Introduced Feb 16, 2023
- In committee Feb 16, 2023
- Died
- Passed the Senate
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
By Representative Coppinger of Boston, a petition (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry. Health Care Financing.
Every action
4 steps, oldest first, as the legislature records them.
- CommitteeReferred to the committee on Health Care Financing · Joint Committee on Health Care Financing
- SenateSenate concurred
- CommitteeHearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2 · Joint Committee on Health Care Financing
- CommitteeAccompanied a new draft, see S2492 · Joint Committee on Health Care Financing
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it, joined by 4 cosponsors: 4 Democrats.
- EF Edward F. CoppingerD Primary sponsor · District 10th Suffolk
All 4 cosponsors
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From Massachusetts's official records (malegislature.gov/api), checked Nov 19, 2026. Text links go to the official versions; LegiList does not copy bill text.